SpringerLink
Log in

Targeting pro-fibrotic macrophages with bioactive self-assembly peptides to retard kidney fibrosis – know thyself

  • Comment
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ouyang Q, Wang C, Sang T, Tong Y, Zhang J, Chen Y, et al. Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis. Cell Mol Immunol 2024;21:826–841.

  2. Awad AS, Rouse M, Huang L, Vergis AL, Reutershan J, Cathro HP, et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 2009;75:689–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ferenbach DA, Sheldrake TA, Dhaliwal K, Kipari TM, Marson LP, Kluth DC, et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice. Kidney Int. 2012;82:928–33.

    Article  CAS  PubMed  Google Scholar 

  4. Hoeft K, Schaefer G, Kim H, Schumacher D, Bleckwehl T, Long Q, et al. Platelet-instructed SPP1(+) macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner. Cell Rep. 2023;42:112131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Fu M, Shu S, Peng Z, Liu X, Chen X, Zeng Z, et al. Single-cell RNA sequencing of coronary perivascular adipose tissue from end-stage heart failure patients identifies SPP1(+) macrophage subpopulation as a target for alleviating fibrosis. Arterioscler Thromb Vasc Biol. 2023;43:2143–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gao X, Jia G, Guttman A, DePianto DJ, Morshead KB, Sun KH, et al. Osteopontin links myeloid activation and disease progression in systemic sclerosis. Cell Rep Med. 2020;1:100140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhou G, Kan X, Zhang F, Ji H, Sun J, Yang X. Interventional oncolytic immunotherapy with LTX-315 for residual tumor after incomplete radiofrequency ablation of liver cancer. Cancers. 2022;14:6093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway. Cell Death Differ. 2017;24:615–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ, Zhao Y, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. J Hepatol. 2017;67:770–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biosciences, Durham University, South Road, Durham, UK

    Steven O’Reilly

Authors
  1. Steven O’Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven O’Reilly.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Reilly, S. Targeting pro-fibrotic macrophages with bioactive self-assembly peptides to retard kidney fibrosis – know thyself. Cell Mol Immunol (2024). https://doi.org/10.1038/s41423-024-01194-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41423-024-01194-2

  • Springer Nature Limited

Search

Navigation